...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ... just for whatever reason...

Hummm,,,I think we all still have to remember that this company is worth $0.00actually until the technology is proven!!!, We do have to do the norm here and live with valuatuons of what ever is  presented,,but in reality the worth of unproven technology is still what it is,,,,,,,,,we will see what the new revised FMV of this company is in a couple of weeks as seen from the perspective of the company.

Share
New Message
Please login to post a reply